WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP Research Development2026-06-233,500$7.80
$27.30kBuy
Fady Ibraham MalikEVP Research Development2026-06-233,500$79.51
$278.29kSell
Robert I. BlumPresident CEO2026-06-157,500$70.46
$528.45kSell
Fady Ibraham MalikEVP Research Development2026-06-093,500$67.98
$237.93kSell
Fady Ibraham MalikEVP Research Development2026-06-093,500$7.80
$27.30kBuy
Edward M. Md KayeDirector2026-06-012,933$76.09
$223.17kSell
Andrew CallosEVP Chief Commercial Officer2026-06-0115,000$74.08
$1.11MSell
B. Lynne ParshallDirector2026-06-015,000$74.08
$370.40kSell
Andrew CallosEVP Chief Commercial Officer2026-06-0115,000$23.26
$348.90kBuy
Robert I. BlumPresident CEO2026-05-277,500$77.21
$579.08kSell

1 of 16

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc14.08%17,523,840$1.44BInstitution
Blackrock Inc13.30%16,548,011$1.36BInstitution
Fmr LLC8.62%10,723,140$881.33MInstitution
Michael Schmertzler7.82%9,730,131$799.72MInsider
Wellington Management Group LLP6.44%8,009,489$658.30MInstitution
Vanguard Portfolio Management LLC4.70%5,843,782$480.30MInstitution
State Street Corp4.62%5,745,193$472.20MInstitution
Vanguard Capital Management LLC4.41%5,488,634$451.11MInstitution
Avoro Capital Advisors LLC2.68%3,333,333$273.97MInstitution
Geode Capital Management LLC2.58%3,215,415$264.27MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK90.50%9.50%Net SellingNet Selling
APGE95.63%4.37%Net SellingNet Selling
NUVL77.73%22.27%Net SellingNet Buying
SMMT8.35%91.65%Net BuyingNet Buying
KRYS79.66%20.34%Net SellingNet Selling
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 117.40% institutional shareholders, 12.33% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 7.82% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $799.72M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.